cardiovascular (heart) disease Archive — Page 1 of 10
-
July 24, 2026
Three Pediatric Heart Institute researchers earn American Heart Association funding awards
More than $500,000 in grants will fuel pioneering work in early disease detection, genetic risk insights and family-centered care for children with heart conditions. -
July 20, 2026
Vanderbilt Health-led registry identifies gaps, aims to improve outcomes for aortic stenosis patients
The registry is the first to track data and evaluate the quality of upstream care processes before valve replacement for patients with aortic stenosis — the most common type of heart valve disease in developed nations. -
June 9, 2026
New guidance document aims to improve postpartum cardiovascular care, prevent deaths
“This is the first cardiovascular society guidance that has been published on postpartum care for women with cardiovascular disease and is a major step forward in evidence-based care to reduce cardiovascular morbidity and mortality in pregnant women.” -
April 28, 2026
National report calls for new guidelines to prevent maternal cardiovascular death
The authors reviewed nine clinical preventive services for maternal cardiovascular health and found sufficient evidence to call for updated clinical guidelines in two areas — better management of chronic hypertension and stronger postpartum blood pressure monitoring. -
April 16, 2026
Monroe Carell Jr. Children’s Hospital at Vanderbilt hosts Southeast Pediatric Cardiac Society Annual Conference
The conference provides a forum to highlight advances in the care of children and adults with congenital heart disease. -
March 20, 2026
Precancerous blood disorder raises risk of inflammatory heart disease
New study suggests that treating patients for CHIP (clonal growth of precancerous blood cells) could reduce their risk of potentially life-threatening heart inflammation. -
March 3, 2026
Vanderbilt Tullahoma-Harton Hospital receives national designation for treating patients with chest pain
Hospitals that earn accreditation have proven exceptional competency in treating patients with heart attack symptoms. The new designation will last until Jan. 31, 2029.